Stocktoria
CYPHERPUNK TECHNOLOGIES INC. CYPH
Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2017-01-24
CYPHERPUNK TECHNOLOGIES INC. financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | $1.5M | $1.5M | — | — | — | — |
| R&D expense | $25.7M | $57.2M | $73.2M | $45.0M | $32.2M | $20.4M | $24.4M | $21.8M | $22.5M | $23.3M |
| Operating income | -$41.1M | -$70.1M | -$87.0M | -$56.8M | -$41.4M | -$28.5M | -$33.5M | -$30.8M | -$32.4M | -$27.3M |
| Interest expense | — | — | — | $54,000 | $41,000 | $39,000 | $23,000 | $19,000 | $528,000 | — |
| Income tax | $5.3M | $585,000 | — | $147,000 | -$24,000 | -$2,000 | -$3,000 | $20,000 | -$157,000 | — |
| Net income | $4.8M | -$67.6M | -$81.4M | -$54.6M | -$40.6M | -$27.5M | -$32.9M | -$23.1M | -$29.7M | -$25.6M |
| EPS (diluted) | $0.07 | $-1.81 | $-3.98 | $-4.82 | $-0.47 | $-0.63 | $-1.47 | $-2.11 | $-3.31 | — |
| Operating cash flow | -$43.9M | -$60.3M | -$43.8M | -$49.0M | -$35.2M | -$26.0M | -$26.9M | -$26.0M | -$22.1M | -$25.3M |
| Free cash flow | — | — | — | — | — | — | -$27.0M | — | -$22.2M | -$25.5M |
| Cash & equivalents | $14.0M | $47.2M | $70.6M | $65.5M | $114.9M | $52.1M | $3.9M | $16.3M | $25.7M | $793,000 |
| Total assets | $163.2M | $49.1M | $72.8M | $70.4M | $117.9M | $54.4M | $7.4M | $19.1M | $29.1M | $6.5M |
| Total liabilities | $9.7M | $14.1M | $12.7M | $11.5M | $10.0M | $7.7M | $9.2M | $9.9M | $17.9M | $36.2M |
| Shareholders' equity | $153.5M | $35.0M | $60.1M | $58.9M | $107.9M | $46.7M | -$1.7M | $9.2M | $11.1M | -$100.2M |
Growth · year-over-year
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | — | — | — | — | +0.0% | — | — | — | — | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.